Form 4: Delcath Systems Director Acquires Stock Options

Director John Richard Sylvester acquired stock options in Delcath Systems, Inc. on May 15, 2025.

Summary

• John Richard Sylvester, a director of Delcath Systems, Inc., acquired stock options on May 15, 2025.
• The options grant the right to buy 22,500 shares of common stock at an exercise price of $16.05.
• The options vest monthly over a year, starting May 15, 2025, contingent on continued service as a director.
• The options expire 10 years from the grant date or two years after the last day of service, whichever is earlier.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it reflects a director's increased stake in the company.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The director's continued service will determine the full vesting of the options over the next year.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one-twelfth per month is a fairly standard vesting arrangement.
• The exercise price of $16.05 would need to be compared to the current market price of DCTH to assess the immediate value of the options.

Key Dates

Keywords

stock options, director, Delcath Systems, DCTH, beneficial ownership, Form 4